Drug Class
monoclonal antibody targeting IL-6 receptor
Type
ingredient
Active Ingredient
satralizumab
📋Overview
Satralizumab is a monoclonal antibody that targets the interleukin-6 (IL-6) receptor, a protein involved in immune system activity. It is primarily associated with conditions that involve abnormal immune responses, particularly neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease affecting the central nervous system. By modulating the immune system, satralizumab helps address inflammation linked to these disorders. Its use reflects advances in targeted therapies for autoimmune neurological conditions.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for satralizumab
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.